# A Study of Bitopertin (RO4917838) in Adults With Non-Transfusion-Dependent (NTD) Beta-Thalassemia

> **NCT03271541** · PHASE2 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 12 (actual)

## Conditions studied

- Beta-Thalassemia

## Interventions

- **DRUG:** Bitopertin

## Key facts

- **NCT ID:** NCT03271541
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-26
- **Primary completion:** 2018-06-29
- **Final completion:** 2018-06-29
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2018-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03271541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03271541, "A Study of Bitopertin (RO4917838) in Adults With Non-Transfusion-Dependent (NTD) Beta-Thalassemia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03271541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*